Pacific Biosciences of California Inc. sell StockNews.com
Start price
18.04.24
/
50%
€1.39
Target price
18.04.25
-
Performance (%)
21.99%
Price
03.05.24
€1.70
Summary
This prediction is currently active. The prediction currently has a disappointing performance of 21.99%. This prediction currently runs until 18.04.25. The prediction end date can be changed by StockNews_com at any time. StockNews_com has 50% into this predictionPerformance without dividends (%)
Name | 1w |
---|---|
Pacific Biosciences of California Inc. | 22.962% |
iShares Core DAX® | -0.922% |
iShares Nasdaq 100 | 0.371% |
iShares Nikkei 225® | 2.224% |
iShares S&P 500 | -0.026% |
Comments by StockNews_com for this prediction
In the thread Pacific Biosciences of California Inc. diskutieren
Pacific Biosciences of California, Inc. (NASDAQ: PACB) was upgraded by analysts at StockNews.com to a "sell" rating.
Ratings data for PACB provided by MarketBeat
Stopped prediction by StockNews_com for Pacific Biosciences of California Inc.
Pacific Biosciences of California Inc.
Start price
Target price
Perf. (%)
€3.86
12.03.24
12.03.24
-
12.03.25
12.03.25
-56.10%
03.05.24
03.05.24
Pacific Biosciences of California Inc.
Start price
Target price
Perf. (%)
€5.85
13.01.24
13.01.24
-
13.01.25
13.01.25
-71.02%
03.05.24
03.05.24
Pacific Biosciences of California Inc.
Start price
Target price
Perf. (%)
€9.37
29.12.23
29.12.23
-
29.12.24
29.12.24
-81.90%
03.05.24
03.05.24